1. Home
  2. FATE vs AEI Comparison

FATE vs AEI Comparison

Compare FATE & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$1.18

Market Cap

139.6M

Sector

Health Care

ML Signal

N/A

Logo Alset Inc. (TX)

AEI

Alset Inc. (TX)

N/A

Current Price

$1.71

Market Cap

119.4M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
FATE
AEI
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
139.6M
119.4M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
FATE
AEI
Price
$1.18
$1.71
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
1.5M
11.0K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.88
93.40
EPS
N/A
N/A
Revenue
$6,646,000.00
$16,238,200.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.70
52 Week High
$1.94
$4.55

Technical Indicators

Market Signals
Indicator
FATE
AEI
Relative Strength Index (RSI) 40.66 34.92
Support Level $0.96 $1.13
Resistance Level $1.35 $3.69
Average True Range (ATR) 0.12 0.18
MACD -0.04 -0.02
Stochastic Oscillator 0.00 24.28

Price Performance

Historical Comparison
FATE
AEI

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

Share on Social Networks: